COMP <GO>
SNWV vs UNH // REVENUE GROWTH (YOY)
SANUWAVE Health Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: SNWV 7
— UNH 4
▲ REVENUE GROWTH (YOY) LEADER: SNWV
LAST: $5.85 (+13.59%) • MKT CAP: $50.3M
revenue-growth
36.30%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNWV | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.10% | 88.31% | -11.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 67.30% | 12.38% | +54.92 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.5x | 15.3x | -7.77 | SNWV | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 6.25% | -1.98 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.20% | 5.32% | +5.88 | SNWV | /operating-margins <GO> |
| Net Profit Margin | 26.80% | 3.53% | +23.27 | SNWV | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 36.30% | 3.33% | +32.97 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.09 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.0 | 55.1 | +7.90 | SNWV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.5x | 17.7x | -14.24 | SNWV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.3M | $359.43B | -$359.38B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNWV REV | UNH REV | SNWV GROSS % | UNH GROSS % | SNWV FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.1M | $447.57B | 77.1% | 88.7% | $1.9M | $16.07B |
| FY 2024 | $32.3M | $400.28B | 75.9% | 88.3% | $2.0M | $20.70B |
| FY 2023 | $19.3M | $371.62B | — | 89.6% | -$4.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
UNH // BETA 0.33